Changes in the amounts of high-energy phosphate compounds associated with the actions of phenylephrine and isoprenaline on smooth and cardiac muscle.
D000255:Adenosine Triphosphate / Q000032:analysis*; D000818:Animals; D001011:Aorta / Q000187:drug effects; D003106:Colon / Q000187:drug effects; D004386:Duodenum / Q000187:drug effects; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects; D006801:Humans; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology*; D009130:Muscle, Smooth / Q000737:chemistry* / Q000187:drug effects; D009206:Myocardium / Q000737:chemistry*; D010646:Phentolamine / Q000494:pharmacology; D010656:Phenylephrine / Q000494:pharmacology*; D010725:Phosphocreatine / Q000032:analysis*; D011433:Propranolol / Q000494:pharmacology; D011817:Rabbits; D051381:Rats
D010725:Phosphocreatine; D010656:Phenylephrine; D000255:Adenosine Triphosphate; D011433:Propranolol; D007545:Isoproterenol; D010646:Phentolamine